|
Volumn 474, Issue 7350 SUPPL., 2011, Pages
|
Perspective: Miles to go before we sleep
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BOCEPREVIR;
PEGINTERFERON ALPHA;
RIBAVIRIN;
TELAPREVIR;
BLOOD;
DISEASE PREVALENCE;
DISEASE TREATMENT;
DOSE-RESPONSE RELATIONSHIP;
DRUG RESISTANCE;
ETHNICITY;
HEALTH RISK;
HEPATITIS;
INHIBITOR;
MEDICINE;
RESEARCH AND DEVELOPMENT;
VIRAL DISEASE;
ANEMIA;
DRUG APPROVAL;
DRUG ERUPTION;
GENOTYPE;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
PRIORITY JOURNAL;
REVIEW;
HEPATITIS C, CHRONIC;
HUMANS;
OLIGOPEPTIDES;
PROLINE;
TIME FACTORS;
|
EID: 79958851236
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/474S8a Document Type: Review |
Times cited : (18)
|
References (0)
|